Group 1 - Tianyi Medical's stock price fell by 5.50%, closing at 42.11 yuan, indicating it is currently in a state of decline since its IPO [1] - The company was listed on the Shenzhen Stock Exchange's ChiNext board on April 7, 2022, with an initial offering price of 52.37 yuan per share, now trading below this price [1] - Tianyi Medical issued 14.736842 million new shares, accounting for 25.00% of the total share capital post-issue, raising a total of 771.7684 million yuan, with a net fundraising amount of 694.5632 million yuan [1] Group 2 - The actual net fundraising amount exceeded the original plan by 184.5632 million yuan, with the initial target set at 510 million yuan [1] - The funds raised are intended for the construction of a production facility for 40 million blood purification devices, 10 million sterile humidified oxygen devices, a comprehensive R&D center, and to supplement working capital [1] - The total issuance costs (excluding VAT) amounted to 77.2052 million yuan, with Guotai Junan Securities receiving underwriting fees of 60.1127 million yuan [1]
破发股天益医疗跌5.5% 2022上市募7.7亿国泰海通保荐